Germany CRAMS Market Outlook to 2018
Rising Healthcare Costs to Drive Future Growth
Region:Europe
Product Code:KR162
April 2014
37
About the Report
The industry research publication titled 'Germany CRAMS Market Outlook to 2018 - Rising Healthcare Costs to Drive Future Growth' presents a comprehensive analysis of market size by value of CRAMS services in Germany. The report entails the market share analysis and company profiles of major players in the CRAMS industry. The future analysis and segmentation by drugs and devices and therapeutic areas have also been discussed in each of the sub-segment.
The pharmaceutical industry in Germany is highly involved in the contract research and manufacturing services, with nearly 70.0% of the clinical trials in the country being industry- funded. An increasing amount has been allocated to CRO and CMO services as the country is facing increasing competition from low cost destinations such as India and China. This has led to a growth of the CRAMS market in Germany which has grown at a CAGR of 11.2% during 2007-2013, witnessing a market size of USD ~ billion in 2013. The CRAMS market in Germany has been dominated by CMO services which has showcased a growth of 9.8% during 2007-2013 reaching a market size of USD ~ billion while the CRO services market reached USD ~ billion in 2013 which is expected to register a CAGR of 16.4% during 2013-2018. The CRAMS market for Germany is dominated by the drugs segment making a contribution of 80.0% in 2013. The drugs segment has majorly been driven by five major therapeutic areas such as oncology, metabolic diseases, central nervous system disorders, cardiovascular diseases and infectious diseases. While oncology has been the largest contributor with a share of 23.0%, the fastest growing segment has been that of infectious diseases which represented growth of 15.3% during 2007-2018. The Germany CRAMS market is highly fragmented with some of the key players including Quintiles, Parexel, Boehringer Ingelheim, Evotec AG and others.
Rising healthcare costs and falling productivity would drive the pharmaceutical industries to increasingly outsource the research and developmental services in the country to save time and cost. The CRAMS market of Germany is expected to grow at a CAGR of 13.9% to register revenues of USD ~ billion by 2018. The CRO industry would progress at a higher rate as compared to the CMO industry while the growth of devices segment would be more than that of drugs.
KEY TOPICS COVERED IN THE REPORT
- The market size of the Germany CRAMS market in terms of value in the last years (2007 - 2013)
- Germany CRAMS market segmentation by CMO and CRO service
- Germany CRAMS market segmentation by Drugs and Devices
- Germany CRAMS for Drugs Market Segmentation by Therapeutic Areas
- Trends and Developments in the CRAMS market in Germany
- Government Rules and Regulations in the CRAMS market in Germany
- Competitive landscape players operating in CRAMS market of Germany (such as Evotec AG, Boehringer Ingelheim, Lonza and others)
- Future projections and macro economic factors of CRAMS market in Germany.
Products
Germany CRAMS, CMO, CRO, Drugs Market, Device Market, Therapeutic Class, Oncology, Infectious Diseases, Metabolism, Cardiovascular, Central Nervous Sy
Companies
Quintiles, Covance, Parexel, Icon PLC, Evotec AG, ADME Bioanalysis, Inventiv Health Inc, Boehringer Ingelheim, Evonik Industries
Table of Contents
1. Germany CRAMS Market Introduction and Size, 2007-2013
2. Germany CRAMS Market Segmentation
2.1. By CMO and CRO Market, 2007-2018
2.2. By Drugs and Devices Market, 2007-2018
2.2.1. Germany CRAMS for Drugs Market Segmentation by Therapeutic Classes, 2007-2018
3. Market Share of Major Players in Germany CRAMS Market, 2013
4. Competitive Landscape of Major Players in Germany CRAMS Market
5. Government Regulations in Germany CRAMS Market
6. Trends and Developments in Germany CRAMS Market
Collaboration Schemes to Promote Innovation in CRAMS industry
7. Germany CRAMS Market Future Outlook and Projections, 2014-2018
8. Macro Economic Factors Affecting Germany CRAMS Market
8.1. Ageing Population (55 Years and Above), 2007-2018
8.2. Total Healthcare Expenditure, 2007-2018
8.3. Gross Domestic Product of Germany, 2007-2018
8.4. Pharmaceutical Industry Spending on Drug Development and Research, 2007-2018
8.5. Personal Disposable Income per Household, 2007-2018
9. Appendix
9.1. Market Definitions
9.2. Abbreviations
9.3. Research Methodology
Data Collection Methods
Approach
Variables (Dependent and Independent)
Multi Factor Based Sensitivity Model
Final Conclusion
9.4. Disclaimer
Why Buy From Us?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.